Skip to content

the Effect of Hyaluronic Acid Intrauterine Wash on Endometrial Receptivity and Pregnancy Outcome

the Effect of Hyaluronic Acid Platelets Rich Plasma on the Endometrial Receptivity and Intracytoplasmic Sperms Injection Outcome

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06937645
Enrollment
120
Registered
2025-04-22
Start date
2023-09-01
Completion date
2025-08-01
Last updated
2025-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertile Patients

Keywords

hyaluronic acid, intrauterine wash, endometrial receptivity, pregnancy outcome

Brief summary

Hyaluronic acid intrauterine wash is done for infertile females undergoing intracytoplasmic sperm injection on the day of oocyte retrieval. endometrial receptivity parameters, including the subendometrial vasculature indices were measured before and after the intervention for purpose of studying the effect of hyaluronic acid on improvement of the endometrial receptivity and subsequently the pregnancy outcome

Interventions

DRUGHyaluronic Acid (HA)

hyaluronic acid PRP preparation used to wash the endometrium on the day of oocytes retrieval

PRP preparation used to wash the uterine cavity on the day of oocytes retrieval

Sponsors

Al-Nahrain University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Infertile females aged 18-40 years. * Infertile females scheduled for GnRH antagonist protocol of fresh ICSI cycle. * Females use dual stimulation (GnRH agonist plus Ovetrelle) for ovulation triggering.

Exclusion criteria

* Infertile females diagnosed as a poor responder. * Infertile females diagnosed with uterine pathology. * Infertile females who are scheduled for a frozen ICSI cycle. * Infertile females diagnosed with endocrine diseases like thyroid disease, diabetes mellitus, and hyperprolactinemia. * Infertile females diagnosed with thrombocytopenia.

Design outcomes

Primary

MeasureTime frameDescription
measuring the value of resistance index (RI) of the sub-endometrial blood vesselsfor each participant twice measure will be done for (RI). The first measure will be performed on the day of oocyte retrieval and the second measure on the day of embryo transfer which is done 3-5 days after oocyte retrieval.We will measure the value of the resistance index (RI) using the transvaginal ultrasound Doppler study. For each patient, RI will be measured twice: the first measure will be done before the intervention on the day of oocyte retrieval, and the second measure will be performed after the intervention on the day of embryo transfer. we will calculate RI according to the following equation Resistance index (RI)= \[Peak Systolic Velocity (PSV) cm/sec - End Diastolic Velocity (EDV) cm/sec \] / Peak Systolic Velocity (PSV) cm/sec Then a statistical comparison will be made to evaluate the difference between the two readings to study the effect of the intervention on the measured parameter for each group.
measuring the value of sub- endometrial vessels pulsatile index (PI)for each participant twice measure will be done for PI. The first measure is on the day of oocyte retrieval and the second measure on the day of embryo transfer which is done 3-5 days after oocyte retrieval.We will measure the value of the pulsatile index (PI) using the transvaginal ultrasound Doppler study. PI will be measured twice for each patient: once before the oocyte retrieval intervention and once after the embryo transfer intervention. then PI will be calculated according to the following equation Pulsatility Index (PI) = \[Peak Systolic Velocity (PSV) cm/sec - end Diastolic Velocity (EDV) cm/sec \] / Mean Velocity (MV) cm/sec Then a statistical comparison will be made to evaluate the difference between the two readings to study the effect of the intervention on the measured parameter for each group.
measuring the value of peak systolic to end diastolic ratio (S/D) of the sub-endometrial blood vesselsfor each participant twice measure will be done for S/D. The first measure is on the day of oocyte retrieval and the second measure on the day of embryo transfer which is done 3-5 days after oocyte retrieval.We will measure the value of the peak systolic to end diastolic ratio (S/D) using the transvaginal ultrasound Doppler study. For each patient, S/D will be measured twice: the first measure will be done before the intervention on the day of oocyte retrieval, and the second measure will be performed after the intervention on the day of embryo transfer. S/D will be calculated according to the following equation S/D= Peak Systolic Velocity (PSV) cm/sec /End Diastolic Velocity (ED) cm/sec Then a statistical comparison will be made to evaluate the difference between the two readings to study the effect of the intervention on the measured parameter for each group.

Secondary

MeasureTime frameDescription
measuring serum level of beta human chorionic gonadotropin2 weeks from the day of oocyte retrievalWe will assess the effect of hyaluronic acid intrauterine wash on improving the pregnancy outcome in infertile patients undergoing intracytoplasmic sperm injection (ICSI). Two weeks after the day of oocyte retrieval, we will measure the serum level of beta human chorionic gonadotropin (B HCG) in mIU/mL to test for successful pregnancy. The pregnancy rates will be compared between the study groups using statistical analysis to see how effective hyaluronic acid intrauterine wash is on pregnancy outcomes compared to the PRP and control groups.

Countries

Iraq

Contacts

Primary Contactghada bassim raaf, Ph.D.
ghadaalanssari@yahoo.co.uk+9647714728261
Backup Contactlubna alanbari, Ph.D.
dr.lubna@st.nahrainuniv.edu.iq07729420158

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026